Navigation Links
Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc.
Date:2/9/2010

t legend, on his American Scene radio program last month and sharing our exciting story with his listeners," commented Dr. Mooney. "We are pleased to again join his popular program to provide listeners with an update on the progress of the product development completion on our Prelude SkinPrep System, the progress of our commercialization strategy and again discuss our market opportunities. The final Prelude device will be tested in the near-term in a study using LMX4 lidocaine cream which should form the basis for the 510-k filing with Ferndale Pharma Group for the enhanced delivery of lidocaine. We believe the addressable market for enhanced, fast acting topical lidocaine exceeds $1 billion. The timing of this interview is fortuitous as we believe we are at an inflection point with our completed product development, our FDA approval process and the beginning of the manufacturing scale-up for validation and product launch, setting the stage for a listing on a national exchange during 2010. We are working with Ferndale Pharma Group to generate cash flow to Echo from the topical anesthetic market in the US and UK during 2010 and we expect to begin generating revenue during 2010."

About Echo Therapeutics

Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units.  Echo is also developing its needle-free Prelude SkinPrep System for transdermal drug delivery of a wide range of novel topical reformulations of widely-used, FDA-approved products.

About Money Channel Inc.

The Money Channel Inc. is headquartered in Coconut Creek, Florida and has operated as a Media Company since 2004, and its CEO, Stephen Crowley is a former Price Waterhouse and Co. CPA-Manager, the former Money E
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 20, 2014  The acceptance of ... 2014 AAGL Global Congress demonstrates continued interest in ... to provide bowel control. One of the abstracts, presented ... and Division Chief of Urogynecology and Reconstructive Pelvic ... an Award for Best Written Abstract on Urogynecology/Pelvic ...
(Date:11/21/2014)... , Nov. 20, 2014   Coqui RadioPharmaceuticals Corp. ... first U.S. commercial producer of Molybdenum-99 (Mo-99), is proud ... INVAP to design its Medical Isotope Production ... Mo-99 is the parent isotope of Technetium-99, which is ... In 2012, Congress passed legislation making it a national ...
(Date:11/21/2014)... , Nov. 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... its previously announced underwritten public offering of $50,000,000 of ... shelf registration statement. The offering will consist of 49,751,244 ... of $1.005 per share.  Lexicon has also granted the ... additional shares of common stock.  All of the shares ...
Breaking Medicine Technology:LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3Coqui RadioPharmaceuticals Inks Deal With INVAP 2Lexicon Announces Pricing Of Common Stock Offering 2Lexicon Announces Pricing Of Common Stock Offering 3
... FDA approvals for prostate cancer treatment medications from ... of men with advanced prostate cancer were prolonged ... & Johnson. The drug, which could reach the market in ... the potential to change clinical practice by providing a new ...
... The Food and Drug Administration (FDA) is warning there ... thigh bone fracture in people who take drugs known ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ... type of fracture has been predominantly reported in patients ...
Cached Medicine Technology:Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone 2
(Date:11/23/2014)... (PRWEB) November 23, 2014 Locks-Magnetic.com, a ... emergency doors. Moreover, all the new products are available ... The marketing manager is proud of the new emergency ... reset automatically. And customers can choose from several colors. ... Buying high quality emergency door release is not as ...
(Date:11/23/2014)... 2014 To show thanks to new and ... of white evening dresses for weddings. Customers who ... , iFitDress.com is a distinguished dress manufacturer, and it is ... worldwide customers for a very long time. The CEO of ... customer will be able to buy not only a beautiful ...
(Date:11/23/2014)... NY (PRWEB) November 23, 2014 More ... past month in a federal litigation involving Byetta lawsuits ... diabetes medications, Bernstein Liebhard LLP reports. , A ... claims over a class of Type 2 diabetes medications ... in the U.S. District Court, Southern District of California, ...
(Date:11/23/2014)... 23, 2014 Asher Milgrom, is ... & Wellness was recently featured on International ... president and CEO of American Medical Aesthetics & Wellness, ... received a full scholarship to attend an M.D./Ph.D program ... at the University of Chicago, where his field of ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 The FDA ... in Common, **FDAnews On-Demand Webinar**, Dec. 11, 2014 ? ... , The FDA’s focus on promotional activities is no ... , Now they're looking at websites, Twitter, journal articles, ... calendar for Thursday, Dec. 11, for On-Demand access to ...
Breaking Medicine News(10 mins):Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5
... standard part of testicular cancer care isnt used in ... condition, researchers at the University of Michigan Comprehensive Cancer ... one indicator of the presence of cancer cells, are ... with testis cancer, including diagnosis, prognostication and surveillance for ...
... 26-Week Study, WILMINGTON, Del., March 17 ... combination asthma therapy,SYMBICORT(R) (budesonide/formoterol fumarate dihydrate), in treating,persistent ... The study examined the,safety of SYMBICORT in children ... children previously treated with inhaled corticosteroid,either alone or ...
... Reduces Surgery Time, AUDUBON, Pa., March ... held spinal implant manufacturer in the world, ... Spacer System. The,new system significantly reduces the ... by offering an unprecedented array of,interoperative options. ...
... Kim Watson to Expand Global Partnerships for Clean Pesticide and Animal ... ... March 17 TyraTech (AIM:,TYR), a pioneer of safer, effective and ... markets, announced today,the appointment of Kim Watson as Senior Director Business ...
... March 17 Conseco, Inc. (NYSE:,CNO) today announced that ... to nominate two of its representatives to Conseco,s board ... strategic,alternatives and has engaged the investment banking firm of ... Prieur said, "We share with Steel Partners, as well ...
... SPRINGVILLE, Calif., March 17 Tropical Traditions,announced today that ... line. It is believed to be the first product ... made from the water inside of coconuts is a,cottage ... Water from,the inside of coconuts is highly valued due ...
Cached Medicine News:Health News:Testicular cancer gauge often not used 2Health News:Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma 2Health News:Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma 3Health News:Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma 4Health News:Globus Medical Launches NIKO(TM) Corpectomy Spacer System 2Health News:TyraTech Adds New Sr. Director Business Development 2Health News:TyraTech Adds New Sr. Director Business Development 3Health News:Tropical Traditions Announces New Organic Raw Coconut Water Vinegar 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: